Analystreport

Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

Opiant Pharmaceuticals, Inc.  (OPNT) 
Last opiant pharmaceuticals, inc. earnings: 3/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.opiant.com/investor-overview